Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018)
Lemaitre Vascular (LMAT) reported Non-Current Deffered Revenue of $530000.0 for Q4 2018, down 5.53% year-over-year from $561000.0 in Q4 2017, and down 1.67% quarter-over-quarter from $539000.0 in Q3 2018.
Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Lemaitre Vascular (LMAT) has 4 years of Non-Current Deffered Revenue data on file, last reported at $530000.0 in Q4 2018.
- Non-Current Deffered Revenue for Q4 2018 came in at $530000.0, down 5.53% year-over-year; the trailing twelve-month figure through Dec 2018 was $530000.0 (down 5.53% YoY), and the FY2018 annual result was $530000.0, down 5.53% from the prior year.
- Non-Current Deffered Revenue fell to $530000.0 in Q4 2018 per LMAT's latest filing, from $539000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $561000.0 in Q4 2017 and troughed at $281000.0 in Q4 2015.
- A 4-year average of $481400.0 and a median of $532000.0 in 2017 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2017 and 2018: Non-Current Deffered Revenue soared 42.39% in 2017, then retreated 5.53% in 2018.
- A 4-year view of Non-Current Deffered Revenue shows it stood at $281000.0 in 2015, then soared by 40.21% to $394000.0 in 2016, then jumped by 42.39% to $561000.0 in 2017, then decreased by 5.53% to $530000.0 in 2018.
- Business Quant data shows LMAT's Non-Current Deffered Revenue at $530000.0 in Q4 2018, $539000.0 in Q3 2018, and $547000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 163.15 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 11.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 530,000.00 |
| Sep 30, 2018 | 539,000.00 |
| Jun 30, 2018 | 547,000.00 |
| Mar 31, 2018 | 554,000.00 |
| Dec 31, 2017 | 561,000.00 |
| Sep 30, 2017 | 534,000.00 |
| Jun 30, 2017 | 452,000.00 |
| Mar 31, 2017 | 422,000.00 |
| Dec 31, 2016 | 394,000.00 |
| Dec 31, 2015 | 281,000.00 |